TY  - JOUR
AU  - Gronchi, Alessandro
AU  - Hindi, Nadia
AU  - Cruz, Josefina
AU  - Blay, Jean-Yves
AU  - Lopez-Pousa, Antonio
AU  - Italiano, Antoine
AU  - Alvarez, Rosa
AU  - Gutierrez, Antonio
AU  - Rincón, Inmaculada
AU  - Sangalli, Claudia
AU  - Pérez Aguiar, Jose Luis
AU  - Romero, Jesús
AU  - Morosi, Carlo
AU  - Sunyach, Marie Pierre
AU  - Sanfilippo, Roberta
AU  - Romagosa, Cleofe
AU  - Ranchere-Vince, Dominique
AU  - Dei Tos, Angelo P
AU  - Casali, Paolo G
AU  - Martin-Broto, Javier
PY  - 2019
DO  - 10.1016/j.eclinm.2019.03.007
UR  - https://hdl.handle.net/10668/27241
T2  - EClinicalMedicine
AB  - Myxoid liposarcoma (ML) exhibits a special sensitivity to trabectedin (T) and radiation therapy (RT). Preclinical data suggest a synergistic effect. We aimed to study safety, feasibility and activity of the administration of pre-operative concurrent T...
LA  - en
KW  - Chemotherapy
KW  - Myxoid Liposarcoma
KW  - Neoadjuvant
KW  - Prognosis
KW  - Radiotherapy
KW  - Sarcoma
KW  - Survival
KW  - Trabectedin
TI  - Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups.
TY  - research article
VL  - 9
ER  -